Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers

Table 3 Analysis of QOL in patients with digestive tract cancer.

	Standard scores				P
	A	B	C	D	P1	P2	P3
Global QL	41.67	56.67	35.00	66.67	0.20	0.71	0.12
Function
PFa	61.43	68.33	69.33	74.67	0.04	0.52	0.12
RFa	67.62	70.83	70.00	76.67	0.02	0.44	0.15
EF	75.00	47.92	93.33	90.00	0.11	0.24	0.25
CF	66.67	50.00	73.33	86.67	0.36	0.69	0.16
SF	47.62	54.17	63.33	56.67	0.79	0.50	0.65
Symptom
FA	50.79	16.67	24.44	25.56	0.10	0.17	0.12
NV	21.43	33.33	10.00	20.00	0.57	0.56	0.93
PA	25.67	29.17	23.03	16.67	0.43	0.26	0.52
Single item
DY	23.33	16.67	23.00	6.00	0.10	0.12	0.10
SLbc	41.00	36.00	18.33	13.33	0.00	0.04	0.36
AP	61.00	41.67	33.33	23.33	0.40	0.23	0.05
COad	55.67	16.67	50.00	10.00	0.04	0.76	0.00
DI	22.33	16.67	15.32	12.15	0.05	0.17	0.14
FI	83.33	66.67	41.67	46.67	0.29	0.55	0.26

^aP<0.05,

^bP<0.01 vs group D;

^cP<0.05 vs group D;

^dP <0.01 vs group D.